<DOC>
	<DOCNO>NCT02547233</DOCNO>
	<brief_summary>The objective trial compare short term efficacy LEO 43204 gel vehicle gel AK face chest apply topically daily 3 consecutive day field treatment .</brief_summary>
	<brief_title>Efficacy Safety LEO 43204 Field Treatment Actinic Keratosis Face Chest Including 12-month Follow-up</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Subjects 5 20 clinically typical , visible discrete AKs within treatment area sundamaged skin either full face contiguous area approximately 250 cm2 ( 40 in2 ) chest Subjects minimum 3 clinically typical , visible discrete AKs within track area 50 cm2 ( 8 in2 ) . The track area must within treatment area Location treatment area ( full face chest ) within 5 cm incompletely heal wound within 5 cm suspect BCC SCC Treatment ingenol mebutate gel treatment area within last 12 month Lesions treatment area : atypical clinical appearance ( e.g . hyperthrophic , hyperkeratotic cutaneous horn ) /or , recalcitrant disease ( e.g . respond cryotherapy two previous occasion ) History evidence skin condition trial indication would interfere evaluation trial medication ( e.g. , eczema , unstable psoriasis , xeroderma pigmentosum )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>